REVELATION BIOSCIENCES, INC. (REVBW) Operating cash flow 2020–2025
REVELATION BIOSCIENCES, INC. (REVBW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.3MFY2025 · since FY2020: -$216,664 → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | +54.9% |
| FY2024 | -$18.3M | -151.4% |
| FY2023 | -$7.3M | +35.1% |
| FY2022 | -$11.2M | -1.2% |
| FY2021 | -$11.1M | -5018.8% |
| FY2020 | -$216,664 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REVBW financial trends
REVBW RevenueREVBW Net incomeREVBW Net marginREVBW Gross profitREVBW Gross marginREVBW Operating incomeREVBW Operating marginREVBW Free cash flowREVBW Capital expendituresREVBW Return on equityREVBW Stock buybacksREVBW Dividends paidREVBW Total assetsREVBW Total liabilitiesREVBW Shareholders’ equityREVBW overview →